Mutual of America Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,216
Closed -$124K 1581
2022
Q3
$124K Buy
2,216
+282
+15% +$18.6K ﹤0.01% 1480
2022
Q2
$140K Buy
1,934
+251
+15% +$18.7K ﹤0.01% 1433
2022
Q1
$134K Buy
1,683
+88
+6% +$7.93K ﹤0.01% 1454
2021
Q4
$161K Sell
1,595
-7
-0.4% -$698 ﹤0.01% 1413
2021
Q3
$148K Sell
1,602
-38
-2% -$3.66K ﹤0.01% 1424
2021
Q2
$168K Buy
1,640
+53
+3% +$5.32K ﹤0.01% 1429
2021
Q1
$155K Buy
1,587
+86
+6% +$7.83K ﹤0.01% 1438
2020
Q4
$116K Buy
1,501
+56
+4% +$4.33K ﹤0.01% 1439
2020
Q3
$106K Buy
1,445
+853
+144% +$68.4K ﹤0.01% 1383
2020
Q2
$43K Buy
592
+33
+6% +$2.59K ﹤0.01% 1381
2020
Q1
$32K Buy
559
+112
+25% +$7.79K ﹤0.01% 1395
2019
Q4
$35K Sell
447
-33
-7% -$2.43K ﹤0.01% 1447
2019
Q3
$33K Buy
480
+7
+1% +$470 ﹤0.01% 1453
2019
Q2
$38K Buy
+473
New +$37.5K ﹤0.01% 1407
2014
Q2
Sell
-1,200
Closed -$45K 1283
2014
Q1
$45K Buy
+1,200
New +$41.9K ﹤0.01% 1219

Other funds holding USNA

Mutual of America Capital Management's USNA Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 2,216 shares — an estimated $124K sold.

Mutual of America Capital Management first reported a position in USNA in Q1 2014 and held it in 15 quarters. The position peaked at $168K in Q2 2021. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,216 Usana Health Sciences shares in Q4 2022, an estimated $124K.
  • Mutual of America Capital Management first reported a position in Usana Health Sciences in Q1 2014 and held it in 15 quarters.
  • Mutual of America Capital Management's Usana Health Sciences position peaked at $168K in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.